Payal Dhar

发表

Antibody targeting tumor-derived soluble NKG2D ligand sMIC provides dual co-stimulation of CD8 T cells and enables sMIC+ tumors respond to PD1/PD-L1 blockade therapy

Bin Zhang, D. Wainwright, Jennifer D. Wu, 2019, Journal of Immunotherapy for Cancer.

NKG2D and its ligands in cancer.

Jennifer D. Wu, Payal Dhar, 2018, Current opinion in immunology.

NKG 2 D and its ligands in cancer

Jennifer D. Wu, Payal Dhar, 2018 .

Anticancer activity of Ophiobolin A, isolated from the endophytic fungus Bipolaris setariae

Dimple R. Bhatia, P. Thiagarajan, S. Deshmukh, 2016, Natural product research.

Tumor-derived NKG2D ligand sMIC reprograms NK cells to an inflammatory phenotype through CBM signalosome activation

D. Wainwright, Zhe Ji, S. Mackay, 2021, Communications biology.

CD38-NAD+Axis Regulates Immunotherapeutic Anti-Tumor T Cell Response.

G. Hardiman, K. Helke, M. Nishimura, 2018, Cell metabolism.

NK Cell Plasticity in Cancer

Jennifer D. Wu, Sizhe Liu, Payal Dhar, 2019, Journal of clinical medicine.

Human NKG2D Ligand Regulation of NK Cell Functions and Metabolism: From Molecular Mechanisms to Therapeutics

Payal Dhar, 2021 .

Targeting metabolism to potentiate NK cell-based therapies

Jennifer D. Wu, Payal Dhar, 2021, Successes and Challenges of NK Immunotherapy.

The carbon impact of artificial intelligence

Payal Dhar, Payal Dhar, 2020, Nature Machine Intelligence.

Antibody targeting tumor-derived soluble NKG2D ligand sMIC reprograms NK cell homeostatic survival and function and enhances melanoma response to PDL1 blockade therapy

J. Sosman, Bin Zhang, D. Wainwright, 2020, Journal of Hematology & Oncology.